A detailed history of Montis Financial, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Montis Financial, LLC holds 513 shares of LLY stock, worth $413,508. This represents 0.16% of its overall portfolio holdings.

Number of Shares
513
Previous 473 8.46%
Holding current value
$413,508
Previous $428,000 6.07%
% of portfolio
0.16%
Previous 0.2%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

BUY
$772.14 - $960.02 $30,885 - $38,400
40 Added 8.46%
513 $454,000
Q1 2024

Apr 16, 2024

BUY
$592.2 - $792.28 $5,329 - $7,130
9 Added 1.94%
473 $367,000
Q4 2023

Feb 06, 2024

BUY
$525.19 - $619.13 $21,007 - $24,765
40 Added 9.43%
464 $270,000
Q3 2023

Oct 31, 2023

BUY
$434.7 - $599.3 $184,312 - $254,103
424 New
424 $227,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $766B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Montis Financial, LLC Portfolio

Follow Montis Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Montis Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Montis Financial, LLC with notifications on news.